Dynavax Technologies | 应收帐款人

金融业

USD

USD 946.51M

现金及等价物

USD 160.25M

USD 14.4M

USD 814.33M

USD 106.84M

USD 285.5M

USD 21.27M

USD 35.53M

405

EPS每股收益

USD 0.21

股本和储备

USD 534.14M

USD 78.57M

债务利息支出

USD 1.64M

USD 6.8M

USD 220.97M

USD 2.04B

USD 18.72M

USD 73.61M

USD 21.27M

普通股股本

USD 117.23M

USD 13.52

USD 28.42M

USD 94.9M

销售和管理费用

USD 40.09M

USD 73.29M

贸易债权人

USD 3.95M

应收帐款人

USD 73.35M

	应收帐款人	更改		日
AbbVie	USD 12.77B		132M	2025-09
Adma Biologics	USD 137.67M		27.94M	2025-09
Agenus	USD 354K		53K	2025-03
Amgen	USD 9.57B		1.08B	2025-12
AstraZeneca	USD 19.05B		1.49B	2025-12
Biogen	USD 1.85B		234M	2025-09
BioMarin Pharmaceutical	USD 790.27M		65.59M	2025-09
Bristol-Myers Squibb	USD 14.62B		485M	2025-09
Dynavax Technologies	USD 73.34M		16.79M	2025-06
Gilead Sciences	USD 4.91B		182M	2025-12
Glaxosmithkline	GBP 11.16B		3.46B	2025-09
Merck	USD 12.12B		596M	2025-09
Nektar Therapeutics	USD 0		2.9M	2024-09
Neurocrine Biosciences	USD 728M		132.3M	2025-09
Novartis	USD 8.98B		192M	2025-09
Pfizer	USD 18.12B		2.02B	2025-09
Regeneron Pharmaceuticals	USD 5.74B		54M	2025-12
Roche Holding	CHF 11.9B		460M	2025-12
Sarepta Therapeutics	USD 395.74M		213.86M	2025-09
TG Therapeutics	USD 265.38M		33.86M	2025-09
Vertex Pharmaceuticals	USD 1.95B		52.9M	2025-09

Dynavax Technologies 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.